NCT00002237View on ClinicalTrials.gov

A Study of Peldesine (BCX-34) in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Peldesine

Trial Locations (1)

94109

Saint Francis Mem Hosp / HIV Care Unit, San Francisco

Sponsors
All Listed Sponsors
lead

BioCryst Pharmaceuticals

INDUSTRY

NCT00002237 - A Study of Peldesine (BCX-34) in HIV-Infected Patients | Biotech Hunter | Biotech Hunter